絞り込み

16386

広告

6528件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

IMPACT OF EGCG SUPPLEMENTATION ON THE PROGRESSION OF DIABETIC NEPHROPATHY IN RATS: AN INSIGHT INTO FIBROSIS AND APOPTOSIS.

Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.

Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts.

Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.

A 3D tri-culture system reveals that activin receptor-like kinase 5 and connective tissue growth factor drive human glomerulosclerosis.

Re-characterization of the Glomerulopathy in CD2AP Deficient Mice by High-Resolution Helium Ion Scanning Microscopy.

Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy.

A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.

The role of angiotensin II in parietal epithelial cell proliferation and crescent formation in glomerular diseases.

Revisiting the determinants of the glomerular filtration barrier: what goes round must come round.

Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly.

Meprin Metalloprotease Deficiency Associated with Higher Mortality Rates and More Severe Diabetic Kidney Injury in Mice with STZ-Induced Type 1 Diabetes.

Helicobacter pylori cytotoxin-associated gene A impairs the filtration barrier function of podocytes via p38 MAPK signaling pathway.

Pharmacological inhibition of FSGS-related TRPC6 gain of function mutants by semisynthetic larixol-derived compounds.

Ultrastructural changes of kidney in Schistosoma mansoni-infected mice.

c‑Maf inducing protein inhibits cofilin‑1 activity and alters podocyte cytoskeleton organization.

Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome.

Oxymorphone Hydrochloride Extended-Release (OPANA®) Associated With Acute Kidney Injury in a Chronic Pain Patient: A Case Report.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります